TITAN BIOTECH LTD. Share Price

₹ 324.25

-₹15.60 (-4.59%)
1D
Last updated 02 Nov, 2026, 15:29 IST
BSE: 524717
|
Pharmaceuticals

TITAN BIOTECH LTD. Share Price Today

As of 3 Nov 2026, TITAN BIOTECH LTD. share price is ₹324.25. The stock opened at ₹345.00, compared to its previous close of ₹339.85. During today's trading session, TITAN BIOTECH LTD. share price moved in the range of ₹322.10 to ₹348.50, with an average price of ₹335.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹137.12 and a high of ₹444.52.

Share price over the last 1 day fell from 348.50 to 324.25, ranging between 324.05 and 348.50.

₹322.10
4.59% down today
₹348.50
1D LOW
1D HIGH

TITAN BIOTECH LTD. Stock Insights

Latest Earning
Op Profit TrendUp by 23.83% QoQ
Latest Earning
Net Profit TrendUp by 44.21% QoQ
Latest Earning
Revenue TrendUp by 19.71% QoQ
Stock Performance
OutperformingBeat Nifty by 5.98 % in last 1 month
TITAN BIOTECH LTD. stock performance
Open₹345.00
High₹348.50
Low₹322.10
Prev. close₹339.85
TITAN BIOTECH LTD. trading activity
Volume23,301
Average traded price₹332.10
Last traded time03:29:45 02 Nov
Last traded quantity64

Circuit
L
H
₹293.05
₹358.15
52-week
L
H
₹137.12
₹444.52
Mkt Cap Cr
1,755.26

P/E
51.81

P/B
9.67

ROA
14.38%
ROE
16.46%

ROCE
20.87%

Quick Ratio
1.14

EV/EBITDA
36.0

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Titan Biotech outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Titan Biotech appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Titan Biotech revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TITAN BIOTECH LTD. Company Background

ISIN
INE150C01029
Sector Market Cap
₹ 1,755.26 Cr

Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.

TITAN BIOTECH LTD. Financial Highlights

  • Revenue: TITAN BIOTECH LTD. reported revenue of ₹211.60 crore in FY26 vs ₹160.36 crore in FY25. It showed an increase of 31.95% on a yearly basis.
  • Operating Profit: TITAN BIOTECH LTD. reported an operating profit of ₹38.17 crore in FY26 vs ₹24.37 crore in FY25. It showed an increase of 56.63% on a year-on-year basis.
  • Net Profit: TITAN BIOTECH LTD. reported a net profit of ₹27.45 crore in FY26 vs ₹18.27 crore in FY25. It showed an increase of 50.25% on a yearly basis.

TITAN BIOTECH LTD. Quarterly Result Highlights

  • TITAN BIOTECH LTD. reported revenue of ₹60.98 crore in Jun 2026, compared with ₹50.94 crore in Mar 2026, representing an increase of 19.71% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported an operating profit of ₹12.73 crore in Jun 2026, compared with ₹10.28 crore in Mar 2026, representing an increase of 23.83% on a quarter-on-quarter (QoQ) basis.
  • TITAN BIOTECH LTD. reported a profit of ₹9.46 crore in Jun 2026, compared with ₹6.56 crore in Mar 2026, reflecting an increase of 44.21% on a QoQ basis.
  • The earnings per share (EPS) of TITAN BIOTECH LTD. stood at ₹7.23 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
55.78%
FII
0.00%
Other DII
0.01%
Retail and other
44.21%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

TITAN BIOTECH LTD. Investment Returns

1 day
-4.19%

1 week
+3.60%

1 month
+3.96%

1 year
+93.04%

3 years
+471.53%

5 years
+580.32%

TITAN BIOTECH LTD. Share Price History

TITAN BIOTECH LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹345.00 / ₹325.60
-4.19%
30 Oct 26
₹364.90 / ₹339.85
-5.72%
29 Oct 26
₹356.15 / ₹360.45
+2.40%
28 Oct 26
₹357.30 / ₹352.00
+8.36%
Show more

TITAN BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹206.19₹156.45₹164.07₹144.00
Other Income₹5.41₹3.91₹1.75₹1.94
Total Revenue₹211.60₹160.36₹165.82₹145.94
Total Expenses₹173.43₹136.00₹134.29₹117.83
Profit Before Tax₹38.17₹24.37₹31.53₹28.12
Tax₹10.73₹6.10₹7.87₹7.09
Profit After Tax₹27.45₹18.27₹23.66₹21.02
EPS - Basic₹7.23₹26.06₹30.07₹30.06
EPS - Diluted₹7.23₹26.06₹30.07₹30.06

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.17₹24.37₹31.53₹28.12
Income before WC changes₹45.37₹29.66₹36.29₹31.64
Change in Assets-₹11.56-₹6.34-₹5.77-₹6.27
Change in Liabilities₹5.17₹2.80-₹1.51₹3.31
Change in WC-₹6.40-₹3.55-₹7.28-₹2.96
Cash flow from Operations₹30.42₹20.12₹21.15₹21.18
Cash flow from Investing-₹32.55-₹9.85-₹20.30-₹20.73
Cash flow from Financing-₹1.53-₹7.98-₹2.87-₹2.40
Total Cash Flow-₹3.65₹2.29-₹2.02-₹1.95
Cash (Start of the year)₹5.13₹2.84₹4.86₹6.81
Cash (End of the year)₹1.48₹5.13₹2.84₹4.86

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹128.64₹95.20₹84.41₹66.21
Current Assets₹85.24₹79.51₹72.62₹68.31
Total Assets₹213.88₹174.71₹157.03₹134.52
Current Liabilities₹25.96₹17.74₹19.57₹20.35
Net Current Asset₹59.28₹61.77₹53.05₹47.96
Non-Current Liabilities₹6.37₹3.57₹4.00₹4.25
Equity Capital₹181.55₹153.40₹133.45₹109.91
Total Equity & Liabilities₹213.88₹174.71₹157.03₹134.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹206.19₹156.45₹164.07₹144.00
Other Income₹5.41₹3.91₹1.75₹1.94
Total Revenue₹211.60₹160.36₹165.82₹145.94
Total Expenses₹173.43₹136.00₹134.29₹117.83
Profit Before Tax₹38.17₹24.37₹31.53₹28.12
Tax₹10.73₹6.10₹7.87₹7.09
Profit After Tax₹27.45₹18.27₹23.66₹21.02
EPS - Basic₹6.64₹22.11₹28.64₹25.44
EPS - Diluted₹6.64₹22.11₹28.64₹25.44

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹38.17₹24.37₹31.53₹28.12
Income before WC changes₹45.37₹29.66₹36.29₹31.64
Change in Assets-₹11.56-₹6.34-₹5.77-₹6.27
Change in Liabilities₹5.17₹2.80-₹1.51₹3.31
Change in WC-₹6.40-₹3.55-₹7.28-₹2.96
Cash flow from Operations₹30.42₹20.12₹21.15₹21.18
Cash flow from Investing-₹32.55-₹9.85-₹20.30-₹20.73
Cash flow from Financing-₹1.53-₹7.98-₹2.87-₹2.40
Total Cash Flow-₹3.65₹2.29-₹2.02-₹1.95
Cash (Start of the year)₹5.13₹2.84₹4.86₹6.81
Cash (End of the year)₹1.48₹5.13₹2.84₹4.86

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹117.94₹86.93₹79.40₹62.39
Current Assets₹85.24₹79.51₹72.17₹68.31
Total Assets₹203.18₹166.44₹151.57₹130.70
Current Liabilities₹25.96₹17.74₹19.13₹20.35
Net Current Asset₹59.28₹61.77₹53.05₹47.96
Non-Current Liabilities₹6.37₹3.57₹4.00₹4.25
Equity Capital₹170.84₹145.13₹128.44₹106.09
Total Equity & Liabilities₹203.18₹166.44₹151.57₹130.70
* All values are in INR Crore
TITAN BIOTECH LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
00325.6467
0000
0000
0000
0000
Total bid quantity0
Total ask quantity467
TITAN BIOTECH LTD. technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
49.19
Neutral

ATR (14)
18.51
Neutral

STOCH(9,6)
33.22
Neutral

STOCH RSI (14)
19.21
Bullish

ADX(9)
20.9
Bearish

UO(9)
44.36
Neutral

ROC(12)
1.77
Bullish

WillR(14)
-66.78
Neutral
Period
Simple value
Exponential vaue

5D
338.29
341.52

10D
333.88
335.42

20D
324.33
329.44

50D
322.91
325.89

100D
326.49
323.61
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

TITAN BIOTECH LTD.
Pharmaceuticals
Add Stock
Add Another

TITAN BIOTECH LTD. Returns Calculator

Ex-date: 23 Oct 2026

Ex-date: 22 Sep 2026

Ex-date: 20 Feb 2026

TITAN BIOTECH LTD. Share Price FAQs












Please be aware that TITAN BIOTECH LTD. stock prices are subject to continuous fluctuations due to various factors.